Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$31.71 - $38.95 $24,892 - $30,575
-785 Reduced 79.37%
204 $8,000
Q3 2023

Nov 13, 2023

SELL
$37.32 - $49.29 $2,761 - $3,647
-74 Reduced 6.96%
989 $37,000
Q2 2023

Aug 15, 2023

SELL
$39.98 - $47.68 $11,794 - $14,065
-295 Reduced 21.72%
1,063 $48,000
Q1 2023

Apr 27, 2023

BUY
$37.58 - $52.57 $32,469 - $45,420
864 Added 174.9%
1,358 $55,000
Q4 2022

Feb 07, 2023

SELL
$49.7 - $57.71 $37,921 - $44,032
-763 Reduced 60.7%
494 $25,000
Q3 2022

Oct 28, 2022

SELL
$53.86 - $66.8 $217,809 - $270,139
-4,044 Reduced 76.29%
1,257 $68,000
Q2 2022

Aug 12, 2022

SELL
$63.83 - $80.0 $7,340 - $9,200
-115 Reduced 2.12%
5,301 $340,000
Q1 2022

May 04, 2022

BUY
$76.85 - $89.45 $230,242 - $267,992
2,996 Added 123.8%
5,416 $420,000
Q4 2021

Feb 07, 2022

BUY
$74.57 - $87.19 $175,164 - $204,809
2,349 Added 3308.45%
2,420 $208,000
Q2 2021

Aug 11, 2021

BUY
$80.5 - $88.01 $80 - $88
1 Added 1.43%
71 $6,000
Q1 2020

May 07, 2020

BUY
$71.57 - $93.3 $71 - $93
1 Added 1.45%
70 $6,000
Q2 2019

Aug 08, 2019

BUY
$73.44 - $82.41 $5,067 - $5,686
69 New
69 $6,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.